Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)
Article in Lung Cancer (September 2022)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Lung Cancer (September 2022)
Article in European Journal of Cancer (August 2022)
Article in Pharmaceuticals (November 2020)